Details for: MEDIPRO
Product description
Product name: MEDIPRO
Company name: THORNE RESEARCH INC.
DIN: 02231935
Status: Cancelled Post Market
Status date: 2009-08-18
| Active ingredient(s) | Strength |
|---|---|
| ASCORBIC ACID (ASCORBIC ACID) | 37.5 MG / 15 G |
| BIOTIN | 75 MCG / 15 G |
| CALCIUM (CALCIUM CITRATE) | 125 MG / 15 G |
| CHOLINE CITRATE | 10 MG / 15 G |
| CHROMIUM (CHROMIUM CITRATE) | 25 MCG / 15 G |
| COPPER (COPPER CITRATE) | 1 MG / 15 G |
| D-PANTOTHENIC ACID | 10 MG / 15 G |
| FOLIC ACID | 0.07 MG / 15 G |
| IODINE (POTASSIUM IODIDE) | 0.2 MG / 15 G |
| IRON (FERRIC CITRATE) | 4 MG / 15 G |
| MAGNESIUM (MAGNESIUM CITRATE) | 50 MG / 15 G |
| MANGANESE (MANGANESE CITRATE) | 2.5 MG / 15 G |
| MOLYBDENUM (MOLYBDENUM CITRATE) | 12.5 MCG / 15 G |
| NICOTINIC ACID | 7.5 MG / 15 G |
| POTASSIUM (POTASSIUM CITRATE) | 49 MG / 15 G |
| SELENIUM (SELENIUM CITRATE) | 25 MCG / 15 G |
| VANADIUM (VANADIUM CITRATE) | 12.5 MCG / 15 G |
| VITAMIN A (BETA-CAROTENE) | 2000 UNIT / 15 G |
| VITAMIN B12 (VITAMIN B12) | 15 MCG / 15 G |
| VITAMIN B1 (THIAMINE HYDROCHLORIDE) | 2.5 MG / 15 G |
| VITAMIN B2 (RIBOFLAVIN-5-PHOSPHATE) | 1 MG / 15 G |
| VITAMIN B6 (PYRIDOXAL-5-PHOSPHATE) | 2.5 MG / 15 G |
| VITAMIN E (D-ALPHA TOCOPHEROL) | 25 UNIT / 15 G |
| ZINC (ZINC CITRATE) | 2.5 MG / 15 G |
Resources
Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.
For consumers
| Resource | Description |
|---|---|
| Report a side effect |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|
For health care professionals
| Resource | Description |
|---|---|
| Report a serious adverse drug reaction (for hospitals) |
Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals. |
For researchers
| Resource | Description |
|---|---|
| Search Clinical Information | After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes. |
All resources
| Resource | Description |
|---|---|
| Search Clinical Information | After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes. |
| Report a side effect |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|
| Report a serious adverse drug reaction (for hospitals) |
Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals. |
| Resource | Description |
|---|---|
| Report a side effect |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|